Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Imunon ( (IMNN) ) has provided an update.
On January 7, 2026, Imunon, Inc. announced that interim Chief Financial Officer Kimberly Graper will resign her role effective January 14, 2026, to pursue another career opportunity, with the company emphasizing that her departure involves no disagreements with management and allowing time for a smooth transition. Effective the same date, Imunon appointed former longtime finance leader Jeffrey Church as interim Chief Financial Officer and principal financial and accounting officer under an amended consulting agreement that sets his retainer and hourly compensation, reinforcing continuity in financial leadership by bringing back an executive deeply familiar with the company’s operations and investor relations.
The most recent analyst rating on (IMNN) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Imunon stock, see the IMNN Stock Forecast page.
Spark’s Take on IMNN Stock
According to Spark, TipRanks’ AI Analyst, IMNN is a Neutral.
The score is primarily constrained by weak financial performance (no revenue, sustained losses, and negative free cash flow) and a longer-term downtrend in technicals. Offsetting factors include constructive earnings-call updates (Phase III progress, regulatory milestone, and lower operating expenses), but near-term liquidity constraints and reliance on external capital remain key risks.
To see Spark’s full report on IMNN stock, click here.
More about Imunon
Imunon, Inc. is a biotechnology company focused on developing life science therapies, operating within the broader biopharmaceutical and life sciences industry. The company’s leadership team includes experienced financial and strategic executives with backgrounds in publicly traded biotech and vaccine development firms, reflecting its positioning in the innovation-driven healthcare sector.
Average Trading Volume: 66,329
Technical Sentiment Signal: Strong Sell
Current Market Cap: $13.43M
For detailed information about IMNN stock, go to TipRanks’ Stock Analysis page.